z-logo
open-access-imgOpen Access
<p>Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States</p>
Author(s) -
Tiffany P. Quock,
Tingjian Yan,
Ryan Tieu,
Anita D’Souza,
Michael S. Broder
Publication year - 2019
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s207127
Subject(s) - medicine , cardiac amyloidosis , amyloidosis , al amyloidosis , disease , cardiac dysfunction , intensive care unit , amyloid fibril , heart failure , immunoglobulin light chain , intensive care medicine , antibody , amyloid β , immunology
Cardiac dysfunction is common in amyloid light-chain (AL) amyloidosis, a rare disease caused by extracellular deposition of misfolded immunoglobulin light chains. This study aimed to examine economic/clinical disease burden in hospitalized cardiac amyloidosis patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here